Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-058476
Filing Date
2014-09-30
Accepted
2014-09-29 17:59:56
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v387691_10k.htm 10-K 792263
2 EXHIBIT 21.1 v387691_ex21-1.htm EX-21.1 3091
3 EXHIBIT 31.1 v387691_ex31-1.htm EX-31.1 11106
4 EXHIBIT 31.2 v387691_ex31-2.htm EX-31.2 11109
5 EXHIBIT 32.1 v387691_ex32-1.htm EX-32.1 5606
6 EXHIBIT 32.2 v387691_ex32-2.htm EX-32.2 5747
  Complete submission text file 0001144204-14-058476.txt   6638401

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT antb-20140630.xml EX-101.INS 896321
8 XBRL TAXONOMY EXTENSION SCHEMA antb-20140630.xsd EX-101.SCH 70078
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20140630_cal.xml EX-101.CAL 53558
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20140630_def.xml EX-101.DEF 340649
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20140630_lab.xml EX-101.LAB 473891
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20140630_pre.xml EX-101.PRE 400810
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54495 | Film No.: 141127869
SIC: 2834 Pharmaceutical Preparations